Table 1. Classification and etiology of congenital hypothyroidism .
|
Permanent congenital hypothyroidism |
|
1.Primary hypothyroidism a) Thyroid dysgenesis: ectopia, athyreosis, hypoplasia, hemiagenesis i) Familial or genetic (2-5% of dygenesis cases): syndrome or associated features (1) NKX2.1: Brain-lung-thyroid syndrome (respiratory distress, choreatetosis) (2) FOXE1: Bamforth-Lazarus syndrome (cleft palate, chonal atresia, spiky hair) (3) PAX8: Hypoplasia, genitourinary anomalies (rare) (4) GLIS3: Athyreosis, neonatal diabetes, cystic kidneys, cholestasis (5) NKX2.5: Athyreosis/ectopy, congenital heart malformations (6) JAG1: Hypoplasia/ectopy, Alagille syndrome type 1 (7) CDC8 (BOREALIN): Ectopy, athyreosis, hemiagenesis (8) NTN1 (Netrin1), TUBB1 (Tubulin1): Ectopy ii) Sporadic (95-98% unknown etiology) b) Dyshormonogenesis: impaired hormone production (±goiter) due to defects in i) Iodide uptake by sodium-iodide symporter (NIS-SLC5A5) ii) Iodide transport from follicular cell into colloid (1) SLC26A4 (PDS): Pendred syndrome (deafness with goiter) (2) SLC26A7: Normal hearing iii) Iodide organification by TPO iv) Hydrogen peroxide generation (1) Dual oxidase 2 (DUOX2) or activator/maturation factor 2 (DUOXA2) (2) Dual oxidase 1 (DUOX1) or activator/maturation factor 1 (DUOXA1) v) Thyroglobulin synthesis (TG) vi) Deiodination by iodotyrosine deiodinase/dehalogenase (IYD-DEHAL1) c) TSH resistance i) Defect in TSH receptor (TSHR): Normal-sized thyroid to severe hypoplasia ii) Defect in G-protein signalling (GNAS): Pseudohypoparathyroidism type 1a d) Syndromic primary hypothyroidism (usually with normal thyroid morphology) i) TBX1: Di George syndorme ii) ELN: Williams-Beuren syndrome iii) DYRK1A: Down syndrome iv) SALL1 (Townes-Brocks), URB1 (Johanson-Blizzard), KMT2D, KDM6A (Kabuki) |
|
2. Central hypothyroidism a) Secondary (pituitary) hypothyroidism i) Isolated TSH deficiency (TSHβ): Low TSH, pitutary hyperplasia ii) TRH receptor resistance (TRHR): Low TSH and prolactin iii) Combined pituitary deficiencies (HESX1, LHX3, LHX4, PIT1, PROP1, SOX3, OTX2) b) Tertiary (hypothalamic) hypothyroidism i) IGSF1: X-linked, low TSH/prolactin, delayed puberty, postpubertal macroorchidism ii) TBLX1, IRS4: X-linked, inappropriately normal TSH, sensorineural deafness iii) Combined pituitary deficiencies (LEPR, PROK2, FGF8, FGFR1, SOX2, CHD7) |
|
Transient congenital hypothyroidism |
|
1) Primary hypothyroidism a) Maternal iodine deficiency (endemic goiter) b) Maternal and neonatal iodine exposure c) Maternal antithyroid medications (methimazole, propylthiouracil) d) Maternal TSH receptor-blocking antibodies e) Genetic defects (DUOX2, DUOXA2, TPO) |
|
2) Central hypothyroidism a) Maternal hyperthyroidism b) Prematurity (particularly <27 weeks of gestation) c) Drugs: Dopamin, steroids |
TPO: thyroid peroxidase, TSH: thyroid-stimulating hormone, FT4: free thyroxine, NHT: neonatal hyperthyrotropinemia